| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:51 UTC |
|---|
| Update Date | 2022-03-07 02:51:52 UTC |
|---|
| HMDB ID | HMDB0015115 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Ramelteon |
|---|
| Description | Ramelteon, also known as rozerem or TAK-375, belongs to the class of organic compounds known as indanes. Indanes are compounds containing an indane moiety, which consists of a cyclopentane fused to a benzene ring. Ramelteon is a drug which is used for the treatment of insomnia characterized by difficulty with sleep onset. Ramelteon is a melatonin receptor agonist with both high affinity for melatonin MT1 and MT2 receptors and selectivity over the MT3 receptor. Ramelteon is an extremely weak basic (essentially neutral) compound (based on its pKa). The most frequent adverse events leading to discontinuation were somnolence, dizziness, nausea, fatigue, headache, and insomnia. It is approved by the U.S. Food and Drug Administration (FDA) for long-term use. Ramelteon and fluvoxamine should not be coadministered. Ramelteon can be used for insomnia, particularly delayed sleep onset. |
|---|
| Structure | CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2 InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Rozerem | Kegg | | TAK-375 | HMDB | | (S)-N-(2-(1,6,7,8-Tetrahydro-2H-indeno-(5,4)furan-8-yl)ethyl)propionamide | HMDB |
|
|---|
| Chemical Formula | C16H21NO2 |
|---|
| Average Molecular Weight | 259.3434 |
|---|
| Monoisotopic Molecular Weight | 259.157228921 |
|---|
| IUPAC Name | N-{2-[(8S)-1H,2H,6H,7H,8H-indeno[5,4-b]furan-8-yl]ethyl}propanamide |
|---|
| Traditional Name | ramelteon |
|---|
| CAS Registry Number | 196597-26-9 |
|---|
| SMILES | CCC(=O)NCC[C@@H]1CCC2=C1C1=C(OCC1)C=C2 |
|---|
| InChI Identifier | InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1 |
|---|
| InChI Key | YLXDSYKOBKBWJQ-LBPRGKRZSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as indanes. Indanes are compounds containing an indane moiety, which consists of a cyclopentane fused to a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Indanes |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Indanes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Indane
- Coumaran
- Alkyl aryl ether
- Carboxamide group
- Secondary carboxylic acid amide
- Oxacycle
- Organoheterocyclic compound
- Ether
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Carbonyl group
- Organopnictogen compound
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.016 g/L | Not Available | | LogP | 2.4 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.12 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.5146 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.8 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1948.3 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 334.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 180.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 185.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 170.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 509.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 576.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 91.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1134.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 464.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1445.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 360.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 353.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 318.6 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 255.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 13.4 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ramelteon,1TMS,isomer #1 | CCC(=O)N(CC[C@@H]1CCC2=CC=C3OCCC3=C21)[Si](C)(C)C | 2392.5 | Semi standard non polar | 33892256 | | Ramelteon,1TMS,isomer #1 | CCC(=O)N(CC[C@@H]1CCC2=CC=C3OCCC3=C21)[Si](C)(C)C | 2344.6 | Standard non polar | 33892256 | | Ramelteon,1TMS,isomer #1 | CCC(=O)N(CC[C@@H]1CCC2=CC=C3OCCC3=C21)[Si](C)(C)C | 2930.5 | Standard polar | 33892256 | | Ramelteon,1TBDMS,isomer #1 | CCC(=O)N(CC[C@@H]1CCC2=CC=C3OCCC3=C21)[Si](C)(C)C(C)(C)C | 2601.4 | Semi standard non polar | 33892256 | | Ramelteon,1TBDMS,isomer #1 | CCC(=O)N(CC[C@@H]1CCC2=CC=C3OCCC3=C21)[Si](C)(C)C(C)(C)C | 2609.3 | Standard non polar | 33892256 | | Ramelteon,1TBDMS,isomer #1 | CCC(=O)N(CC[C@@H]1CCC2=CC=C3OCCC3=C21)[Si](C)(C)C(C)(C)C | 3060.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Ramelteon GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a7r-9870000000-1c290026ffceb3eef315 | 2017-08-28 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ramelteon GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ramelteon GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Ramelteon , positive-QTOF | splash10-0nmi-2980000000-5ee1e7ec83e5c4578dfe | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 10V, Positive-QTOF | splash10-0w29-0190000000-5ab5aa60e4a12e68a700 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 20V, Positive-QTOF | splash10-0uki-2950000000-2f78e21b2259ce9f7f74 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 40V, Positive-QTOF | splash10-0a4i-1900000000-72904ed8a2217e0540cf | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 10V, Negative-QTOF | splash10-0a4i-1090000000-86053c1f7ca9207210fd | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 20V, Negative-QTOF | splash10-0ab9-6290000000-07567898b89338a73662 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 40V, Negative-QTOF | splash10-00dl-9200000000-fd494970ea1477bf6bff | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 10V, Positive-QTOF | splash10-03dr-0490000000-7c5eda0bc1fa87f8d3fe | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 20V, Positive-QTOF | splash10-0f79-0960000000-bc3bd3e1b1625882b5e5 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 40V, Positive-QTOF | splash10-0a4r-1900000000-4d81e2b61e8cc443fe5c | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 10V, Negative-QTOF | splash10-0a4i-0090000000-c0454357e4d45524bed6 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 20V, Negative-QTOF | splash10-006x-9020000000-247d500a821bd4bc62c3 | 2021-10-11 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ramelteon 40V, Negative-QTOF | splash10-006x-3910000000-9a203e7c37bf89bf657d | 2021-10-11 | Wishart Lab | View Spectrum |
|
|---|
| General References | - Karim A, Tolbert D, Cao C: Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. J Clin Pharmacol. 2006 Feb;46(2):140-8. [PubMed:16432265 ]
- Roth T, Stubbs C, Walsh JK: Ramelteon (TAK-375), a selective MT1/MT2-receptor agonist, reduces latency to persistent sleep in a model of transient insomnia related to a novel sleep environment. Sleep. 2005 Mar;28(3):303-7. [PubMed:16173650 ]
- Miyamoto M: Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS Neurosci Ther. 2009 Winter;15(1):32-51. doi: 10.1111/j.1755-5949.2008.00066.x. [PubMed:19228178 ]
- Pandi-Perumal SR, Srinivasan V, Spence DW, Moscovitch A, Hardeland R, Brown GM, Cardinali DP: Ramelteon: a review of its therapeutic potential in sleep disorders. Adv Ther. 2009 Jun;26(6):613-26. doi: 10.1007/s12325-009-0041-6. Epub 2009 Jun 30. [PubMed:19568703 ]
- Borja NL, Daniel KL: Ramelteon for the treatment of insomnia. Clin Ther. 2006 Oct;28(10):1540-55. [PubMed:17157111 ]
- Simpson D, Curran MP: Ramelteon: a review of its use in insomnia. Drugs. 2008;68(13):1901-19. [PubMed:18729542 ]
|
|---|